Anavex Life Sciences: Promising Developments and Strategic Growth Opportunities Justify Buy Rating
Express News | Anavex Life Sciences Corp - Top Line Data Expected in Second Half of 2025
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX3-71 for the Treatment of Schizophrenia
Express News | Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of Anavex®3-71 for the Treatment of Schizophrenia
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
12 Health Care Stocks Moving In Monday's After-Market Session
We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn
Express News | Anavex Life Sciences Announces Appointment of DR. Audrey Gabelle, Md, Phd to the Scientific Advisory Board
Press Release: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years
Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Express News | Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results From Phase Iib/III Open-Label Extension Trial in Early Alzheimer’s Disease
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results From Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)
Anavex Life Sciences Corp.'s (NASDAQ:AVXL) Shift From Loss To Profit